ET
CLBT icon

Entropy Technologies’s Cellebrite CLBT Stock Holding History

Entropy Technologies’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Buy
+14,920
New +$197K 0.01% 865
2025
Q3 		– Sell
-42,816
Closed -$685K – 855
2025
Q2 		$685K Buy
42,816
+8,865
+26% +$158K 0.05% 397
2025
Q1 		$660K Buy
+33,951
New +$715K 0.06% 368

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Entropy Technologies's CLBT Position: Q2 2026 in Review

Entropy Technologies opened a new position in Cellebrite (CLBT) in Q2 2026: 14,920 shares worth $218K. The stake represents 0.01% of the portfolio and ranks #865 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in CLBT as recently as Q2 2025.

Entropy Technologies first reported a position in CLBT in Q1 2025 and has held it in 3 quarters since. The position peaked at $685K in Q2 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Entropy Technologies held 14,920 shares of Cellebrite worth $218K as of Q2 2026.
  • Cellebrite was a new Entropy Technologies position in Q2 2026.
  • Cellebrite made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #865 holding.
  • Entropy Technologies first reported a position in Cellebrite in Q1 2025 and has held it in 3 quarters since.
  • Entropy Technologies's Cellebrite position peaked at $685K in Q2 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.